A major breakthrough in cancer study is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant suppressor protein is frequently disabled in many kinds of cancer, causing https://bookmarkmoz.com/story21961144/vhh-fragments-restore-p53-new-new-pathway-for-cancer-management